Beranda › Nefrosis Lipoid › Michigan
Uji klinis Nefrosis Lipoid di Michigan
5 studi untuk Nefrosis Lipoid mencari peserta di lokasi di Michigan.
Kota di Michigan
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- University of Michigan Health System - Ann Arbor- Site Number : 8400010, Ann Arbor
Menerima pesertaFase 2
Usia 16 hingga 75 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06500702Nephrotic Syndrome Study Network
- CS Mott Children's Hospital, University of Michigan, Ann Arbor
- University of Michigan Medical Center, Ann Arbor
Menerima pesertaStudi observasional
Hingga usia 80 · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- C.S. Mott Children's Hospital, Ann Arbor
Menerima pesertaFase 2
Usia 1 hingga 17 · Semua jenis kelamin · Diperbarui 12 Mei 2026 · NCT05003986Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
- University of Michigan, Ann Arbor
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 29 Apr 2026 · NCT05650619Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
- University of Michigan, Ann Arbor
Menerima pesertaStudi observasional
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 22 Des 2025 · NCT05505500Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.